![Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire](https://mms.businesswire.com/media/20220304005319/en/739014/22/teva_RGB_JPEG.jpg)
Teva Announces Launch of a First Generic Version of Revlimid® (lenalidomide capsules), in the U.S. | Business Wire
Teva Pharmaceuticals USA - As the world's largest manufacturer of quality generic medicines, we're proud to produce many of the drugs on the WHO's Essential Medicines List. Find out more here: https://bit.ly/3Au4h3X #
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA](https://www.fda.gov/files/styles/recall_image_small/public/3_0.jpg?itok=XHGQjr3j)
Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of all Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets that are Within Expiry | FDA
![ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business](https://mms.businesswire.com/media/20180914005613/en/678526/5/AJOVY+Image.jpg)
ADDING MULTIMEDIA Teva Announces U.S. Approval of AJOVYTM (fremanezumab-vfrm) Injection, the First and Only Anti-CGRP Treatment with Both Quarterly and Monthly Dosing for the Preventive Treatment of Migraine in Adults | Business
![テバ|Teva レディース 通販 Teva テバ W MIDFORM UNIVERSAL レディースサンダル【軽量】(ウィメンズミッドフォームユニバーサル) 1090969 BNBH ブラウンバーチ | ジーフットシューズマルシェ/アスビー【公式】 テバ|Teva レディース 通販 Teva テバ W MIDFORM UNIVERSAL レディースサンダル【軽量】(ウィメンズミッドフォームユニバーサル) 1090969 BNBH ブラウンバーチ | ジーフットシューズマルシェ/アスビー【公式】](https://s3-ap-northeast-1.amazonaws.com/gfoot-ec/products/594138/product/566281309096950_1.jpg?1651043426)
テバ|Teva レディース 通販 Teva テバ W MIDFORM UNIVERSAL レディースサンダル【軽量】(ウィメンズミッドフォームユニバーサル) 1090969 BNBH ブラウンバーチ | ジーフットシューズマルシェ/アスビー【公式】
![New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel](https://static.timesofisrael.com/www/uploads/2018/07/teva.jpg)
New York jury finds Israeli drugmaker Teva guilty of helping fuel opioid crisis | The Times of Israel
![Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal](https://media.bizj.us/view/img/6047051/img0195*1024xx2490-1403-0-608.jpg)
Teva Pharmaceutics USA acquires three buildings for an R&D campus in West Chester - Philadelphia Business Journal
Teva Pharmaceuticals USA - Getting the right dosage is critical when patients are administering their own medicine. Our expert Mike Smith explains how we make effective medical devices and combination products here:
![Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal Teva selects North Jersey site for its new North American headquarters. - Philadelphia Business Journal](https://media.bizj.us/view/img/10278469/unknown-6*1200xx2016-1136-0-122.jpg)